TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06604780

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transitional discharge program
Description: For patients classified in the low-risk group, general measures would be applied. For patients in the medium-risk group, reinforced measures would be implemented. Lastly, for patients considered to be in the high-risk group, intensive case management measures would be applied, and if they meet the inclusion criteria, they would be included in the Post-Discharge Group Psychotherapeutic Intervention.~1. General measures~2. Reinforcement measures~3. Intensive measures~   * Intensive case management measures~  * Post-Discharge Psychotherapeutic Recovery Support Program: For application to patients at high risk of early readmission who meet the inclusion criteria. It consists of a multicomponent group psychotherapeutic intervention from a rehabilitative and recovery-oriented perspective. This intervention will be structured into 20 sessions, each lasting 90 minutes, held weekly in an open format.
Study: NCT04806854

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LUM-201
Description: Administered orally once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LUM-201
Description: Administered orally once daily
Study: NCT06605040

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dissemination via Social Media
Description: Participants in the experimental group will follow a scientific Instagram profile where content will be shared. The profile will remain open, allowing permanent access to all posts. To optimize Instagram\&amp;amp;#39;s algorithm, we will use an existing active profile. Any control group participants already following the profile will be removed upon allocation.~For each selected article, we will create three presentations using Instagram features like carousel images and short videos, shared as posts, stories, and reels. This strategy will provide content for 30 weeks of daily posts. Each post will feature visually appealing graphics to convey scientific information and support evidence-based practice (EBP) competencies.
Study: NCT05001659

Intervention type: OTHER
Group type: OTHER
Intervention: computer simulator and mannequin simulator
Description: compared two different training simulators with respect to training effectiveness in ACLS training.

Intervention type: OTHER
Group type: OTHER
Intervention: computer simulator and mannequin simulator
Description: compared two different training simulators with respect to training effectiveness in ACLS training.
Study: NCT06605040

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dissemination via Email
Description: The participant allocated to the control group will receive a different summary each day, along with a link to the full article. This strategy was chosen to replicate the approach used by scientific journals to disseminate new issues.
Study: NCT06608979

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Screening/Referral and Prevention
Description: Session 1: One hour PTSD Screening/referral and Psychoeducation on interpersonal violence (consent, drug-and-alcohol-facilitated assault, intimate partner violence); Session 2: One hour sessions on Protective Behavioral Strategies for interpersonal violence (skills training)
Study: NCT06601647

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: adjuvant type
Description: ropivacaine combined with adjuvant

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: adjuvant type
Description: ropivacaine combined with adjuvant

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: adjuvant type
Description: ropivacaine combined with adjuvant

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: adjuvant type
Description: ropivacaine combined with adjuvant
Study: NCT06608329

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1002
Description: Single dose, administered orally. The study is a randomized, open-label, single dose, 3-period, 3 sequence, crossover design.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1002
Description: Single dose, administered orally. The study is a randomized, open-label, single dose, 3-period, 3 sequence, crossover design.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1002
Description: Single dose, administered orally. The study is a randomized, open-label, single dose, 3-period, 3 sequence, crossover design.
Study: NCT06606470

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: All providers Better Communication Skills program' (ABCs) interprofessional provider education
Description: The 'All providers: Better Communication Skills program' (ABCs) is a virtual, person-centred education curriculum for interprofessional health care providers. The ABCs program adopts a blended format (i.e., participants engage in both asynchronous online modules \[five\] and synchronous interactive workshops \[three\]) that has relevance to learners and clinicians at all levels of training and practice. The ABCs program focuses on four essential elements of being a skillful communicator: principles of effective communication, conversation structure, communication skills, and reflective practice. The program consists of virtual modules that provide any clinician with practical tools, tips, and strategies to implement when communicating with seriously ill patients and their families. Terminology is clarified and consistent, the complexities of conversations are simplified and the fundamental approach and structure can be applied to different contexts.
Study: NCT06607133

Intervention type: PROCEDURE
Intervention: surgery
Description: patients undergo conventional/open thyroidectomy or endoscopic thyroidectomy for large benign thyroid nodules

Intervention type: PROCEDURE
Intervention: staged thermal ablation
Description: patients undergo multiple sessions of thermal ablation for large benign thyroid nodules
Study: NCT06588855

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7790121
Description: RO7790121 will be administered as IV infusion. RO7790121 will be administered as SC injection.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching IV RO7790121. Placebo matching SC RO7790121.
Study: NCT06609070

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHG0521 Oral Coating
Description: The subjects will receive an oral coating of CHG0521 in the form of drops, in addition to the clinician\&#39;s standard treatment regimen, for a duration of 6 months or until confirmed progression, unacceptable toxicity, or any criteria for withdrawal from the trial.
Study: NCT06607042

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Psychotherapy according to the Berlin Dissexuality Therapy (BEDIT)
Study: NCT05032690

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bosutinib capsule
Description: Bosutinib four 25 mg capsule taken after a high-fat and high calorie breakfast

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bosutinib capsule
Description: Bosutinib 100 mg capsule taken after a high-fat and high calorie breakfast

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bosutinib
Description: Bosutinib 100 mg capsule taken after an overnight fast of at least 10 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bosutinib capsule
Description: Bosutinib 100 mg capsule taken after a high-fat and high-calorie breakfast
Study: NCT06605898

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MIND Diet
Description: Daily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MIND Diet
Description: Daily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Diet
Description: Daily meals designed to increase fruit, vegetable, and whole grain intake consistent with a healthy American diet.
Study: NCT04428190

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Human Milk Oligosaccharides (HMO)
Description: Sachet containing 10 grams of HMO

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sachet manufactured to mimic 10g of HMO
Study: NCT06352892

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maridebart Cafraglutide
Description: Solution for SC injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maridebart Cafraglutide
Description: Solution for SC injection.
Study: NCT05707351

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adynovate
Description: Adynovate will be injected intravenously using an appropriately sized syringe as a bolus infusion over a period of less than or equal to (\<=) 5 minutes (maximum infusion rate, 10 milliliters per minute \[mL/min\]).
Study: NCT06699940

Intervention type: DEVICE
Intervention: Transcranial Magnetic Stimulation
Description: Patients between the age of 12-21 received TMS treatment for MDD disorder.
Study: NCT06743256

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgical System
Description: Levita Magnetic Surgical System
Study: NCT06760975

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vestibular Habituation Exercises
Description: The vestibular habituation exercise group follows a structured progression over six weeks. in week 1 participants perform large amplitude, rapid cervical rotations seated, completing 3 sets of five cycles each. By week 2, the exercises increase in complexity , incorporates standing pivots or seated trunk flexion extension. in week 3 the cervical rotations are continued with seated or standing posture. week 4 introduces a busy visual background during the exercise to challenge visual-vestibular integration. In week 5 the exercises are performed standing with the addition complex visual target against a busy background. finally week 6 includes most advance movement including standing pivots 180 degrees and brand-daroff exercises with further visual challenges of near and far targets in busy background. Each exercise session last for 2 minutes and is aimed at progressively enhancing vestibular processing and adaptability.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ocular Reflex Excercises
Description: The Ocular reflex exercises focuses on enhancing visual tracking and reflexes through targeted viewing exercises. In week 1, participants perform horizontal and vertical X1 viewing exercises with a near target, holding each position for 1 minute while seated. In week 2 the duration of the X1 exercises is extended to 2 minutes with the near target still in seated position. Week 3 shift to a far target for the X1 exercises and the participants performs them while standing increasing the challenge. By week 4 the exercise incorporate both near and far target in front of a busy background. extending the duration to 2 minutes while standing. In week 5 horizontal and vertical X2 viewing exercises are added with a plain background, while still using near and far targets in front of a busy background . finally week 6 continues the X1 and X2 exercises with near and far targets in a busy background, performed for 2 minutes while standing. This aims to improve visual tracking.
Study: NCT06761911

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Brentuximab Vedotin (Bv)
Description: 1.2mg/kg/2w or 1.8mg/kg/3w

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Brentuximab Vedotin (Bv)
Description: 1.2mg/kg/2w or 1.8mg/kg/3w

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sintilimab
Description: 200mg/3w

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab
Description: 200mg/3w

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bendamustine
Description: 90mg/m2/3w
Study: NCT06760663

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The load-velocity relationship: Neuromuscular adaptations to resistance training
Description: Comparing the impact of adjusting training load based on movement velocity on hypertrophy and neural adaptations.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The load-velocity relationship: Neuromuscular adaptations to resistance training
Description: Comparing the impact of adjusting training load based on movement velocity on hypertrophy and neural adaptations.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The load-velocity relationship: Neuromuscular adaptations to resistance training
Description: Comparing the impact of adjusting training load based on movement velocity on hypertrophy and neural adaptations.
Study: NCT06762496

Intervention type: OTHER
Intervention: Healthcare professionals
Description: healthcare professionals (HCPs) targeted, including team members: we will involve 30 physicians (who are involved in the process of care towards patients with early breast cancer (10 oncologists, 10 breast surgeon, and 10 breast radiologists specifically) for the semi-structured interviews

Intervention type: OTHER
Intervention: Patients PDA group
Description: Participants will receive via mail the final version of the PDA and a Qualtrics link with a battery of questionnaires

Intervention type: OTHER
Intervention: Patients control group
Description: Participants will receive only the online link with the battery of questionnaires
Study: NCT06761040

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intrinsic foot muscle training
Description: Technique In intrinsic foot muscle training, there are following exercises:~1. Toe spread out~2. First toe extension~3. Second to fifth toe extension The exercise would be performed in following positions 1. Sitting position for the first 2 weeks (3sec hold; 4 sets ×15 reps) 2. Standing position on the 3rd and 4th weeks (8sec hold; 4 sets × 8 reps) 3. One-leg standing position during the 5th and 6th week (20 sec hold;4 sets ×3 reps)
Study: NCT04767191

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: artemether lumefantrine
Description: The drugs are approved and in use by the Kenya Ministry of Health as the 1st and 2nd line treatment for malaria. The study is to assess the continued efficacy of the two drugs in the treatment of uncomplicated malaria.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dihydroartemisinin piperaquine
Description: Antimalarial Combinations
Study: NCT05772247

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung ultrasound
Description: Lung ultrasound score was calculated by the results of lung ultrasound examination

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung ultrasound
Description: Lung ultrasound score was calculated by the results of lung ultrasound examination
Study: NCT06089200

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus Abdominal Plane Block
Description: 20 cc of bupivacaine 0.2% was given to the transversus abdominis plane

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Morphine
Description: 100 µg was administered intrathecally preoperatively
Study: NCT06761040

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intrinsic foot muscle training
Description: Technique In intrinsic foot muscle training, there are following exercises:~1. Toe spread out~2. First toe extension~3. Second to fifth toe extension The exercise would be performed in following positions 1. Sitting position for the first 2 weeks (3sec hold; 4 sets ×15 reps) 2. Standing position on the 3rd and 4th weeks (8sec hold; 4 sets × 8 reps) 3. One-leg standing position during the 5th and 6th week (20 sec hold;4 sets ×3 reps)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hip abductor muscle training with intrinsic foot muscle training
Description: Hip abductor muscle training consists of the following two exercise~1. Resisted hip abduction 90° (2 sec hold; 3 sets × 10 reps)~2. Resisted hip abduction 45° (2 sec hold; 3 sets × 10 reps)~Standard treatment~* Shoe insoles (eight hours a day, medial longitudinal arch support,raised for by about 1.8 cm)~* Stretching of Hamstrings and Calf muscles (3 times for 30 seconds hold) Number of Sessions Per Week : 3 times Per week for 6 weeks
Study: NCT04720612

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Omalizumab
Description: Single subcutaneous dose of 375mg of omalizumab and standard of care.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single subcutaneous dose of normal saline in a syringe identical to that of the omalizumab arm and standard of care.
Study: NCT06112600

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VR
Description: Virtual reality glasses were used as a distraction method for children during vaccination.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kaleidoscope
Description: Kaleidoscope toys were used as a distraction method for children during vaccination.
Study: NCT04652869

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Transcranial direct current stimulation targeting the dorsolateral prefrontal cortex
Study: NCT06761404

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: taVNS
Description: Experimental. The current will be increased gradually for both sham and real stimulation at the beginning of the 90-minute stimulation to lessen the itchy/numb skin sensation and to create the same skin sensation for subject blinding.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: taVNS
Description: Experimental. The current will be increased gradually for both sham and real stimulation at the beginning of the 90-minute stimulation to lessen the itchy/numb skin sensation and to create the same skin sensation for subject blinding.
Study: NCT06761495

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Baseball Suturing Technique
Description: (Baseball Suturing Technique): A corner suture was placed at the right corner of the incision. Next, the second stitch was placed at the apex of the left corner and tied with a knot. Then, the free end of the suture was cut and running baseball stitch pattern was started. The suturing pattern was performed by taking bites from the inside out through the upper and lower lips of the wound at approximately 1 cm intervals with a 1 cm margin from the wound edges

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Baseball Suturing Technique
Description: (Baseball Suturing Technique): A corner suture was placed at the right corner of the incision. Next, the second stitch was placed at the apex of the left corner and tied with a knot. Then, the free end of the suture was cut and running baseball stitch pattern was started. The suturing pattern was performed by taking bites from the inside out through the upper and lower lips of the wound at approximately 1 cm intervals with a 1 cm margin from the wound edges
Study: NCT06761495

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-Layer Locked Continuous Suturing Technique
Description: (Single-Layer Locked Continuous Suturing Technique): A corner suture was placed at the right corner of the incision. Next, the second stitch was placed at the apex of the left corner and tied with a knot. Then, the free end of the suture was cut and single-layer-locked continuous suturing was started. The suturing pattern was performed by taking bites from outside to inside through the lower lip and inside to outside through the upper lip of the wound. Each time, a lock was formed by passing through the loop formed by the previous suture. The suturing was performed at approximately 1 cm intervals with a 1 cm margin from the wound edges

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-Layer Locked Continuous Suturing Technique
Description: (Single-Layer Locked Continuous Suturing Technique): A corner suture was placed at the right corner of the incision. Next, the second stitch was placed at the apex of the left corner and tied with a knot. Then, the free end of the suture was cut and single-layer-locked continuous suturing was started. The suturing pattern was performed by taking bites from outside to inside through the lower lip and inside to outside through the upper lip of the wound. Each time, a lock was formed by passing through the loop formed by the previous suture. The suturing was performed at approximately 1 cm intervals with a 1 cm margin from the wound edges

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-Layer Unlocked Continuous Suturing Technique
Description: (Single-Layer Unlocked Continuous Suturing Technique): The uterotomy line was closed in a single-layer continuous suturing pattern that is explained above as group 2 but without passing the needle through the loop formed by the previous sutu

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-Layer Unlocked Continuous Suturing Technique
Description: (Single-Layer Unlocked Continuous Suturing Technique): The uterotomy line was closed in a single-layer continuous suturing pattern that is explained above as group 2 but without passing the needle through the loop formed by the previous sutu
Study: NCT06760702

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 200mg
Description: AUR109 200mg (once daily)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 200mg
Description: AUR109 200mg (once daily)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 200mg
Description: AUR109 200mg (once daily)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 300mg
Description: AUR109 300mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 300mg
Description: AUR109 300mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 300mg
Description: AUR109 300mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 400mg
Description: AUR109 400mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 400mg
Description: AUR109 400mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 400mg
Description: AUR109 400mg once daily
Study: NCT06760156

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafasitamab
Description: The recommended dose of tafasitamab is 12 mg/kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: The starting dose for lenalidomide will be 25 mg PO daily.
Study: NCT06762678

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: RNA sequencing and whole genome sequencing in a trio way
Description: Patient is not required to be blinded

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: RNA sequencing and whole genome sequencing in a trio way
Description: Patient is not required to be blinded